Joseph E Levitt

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. doi request reprint The pathogenetic and prognostic value of biologic markers in acute lung injury
    Joseph E Levitt
    Division of Pulmonary Critical Care, Stanford University, Stanford, California 94305, USA
    J Intensive Care Med 24:151-67. 2009
  2. pmc Early acute lung injury: criteria for identifying lung injury prior to the need for positive pressure ventilation*
    Joseph E Levitt
    Division of Pulmonary Critical Care, Stanford University, Stanford, CA, USA
    Crit Care Med 41:1929-37. 2013
  3. pmc Diagnostic utility of B-type natriuretic peptide in critically ill patients with pulmonary edema: a prospective cohort study
    Joseph E Levitt
    Division of Pulmonary and Critical Care Medicine, Stanford University Medical Center, 300 Pasteur Drive, MC 5236, Stanford, CA 94305, USA
    Crit Care 12:R3. 2008
  4. pmc Identification of early acute lung injury at initial evaluation in an acute care setting prior to the onset of respiratory failure
    Joseph E Levitt
    Stanford University, 300 Pasteur Drive, Stanford, CA 94305, USA
    Chest 135:936-43. 2009
  5. pmc The utility of clinical predictors of acute lung injury: towards prevention and earlier recognition
    Joseph E Levitt
    Division of Pulmonary Critical Care, Stanford University, 300 Pasteur Drive, MC 5236 Stanford, CA 94305, USA
    Expert Rev Respir Med 4:785-97. 2010
  6. ncbi request reprint Treatment of acute lung injury: historical perspective and potential future therapies
    Joseph E Levitt
    Division of Pulmonary and Critical Care, Stanford University, Stanford, California 94305, USA
    Semin Respir Crit Care Med 27:426-37. 2006

Detail Information

Publications7

  1. doi request reprint The pathogenetic and prognostic value of biologic markers in acute lung injury
    Joseph E Levitt
    Division of Pulmonary Critical Care, Stanford University, Stanford, California 94305, USA
    J Intensive Care Med 24:151-67. 2009
    ..This article provides a review of biologic markers in acute lung injury, with an emphasis on recent analysis of results from multicenter clinical trials...
  2. pmc Early acute lung injury: criteria for identifying lung injury prior to the need for positive pressure ventilation*
    Joseph E Levitt
    Division of Pulmonary Critical Care, Stanford University, Stanford, CA, USA
    Crit Care Med 41:1929-37. 2013
    ..We sought to empirically derive clinical criteria for a pragmatic definition of early acute lung injury to identify patients with lung injury prior to the need for positive pressure ventilation...
  3. pmc Diagnostic utility of B-type natriuretic peptide in critically ill patients with pulmonary edema: a prospective cohort study
    Joseph E Levitt
    Division of Pulmonary and Critical Care Medicine, Stanford University Medical Center, 300 Pasteur Drive, MC 5236, Stanford, CA 94305, USA
    Crit Care 12:R3. 2008
    ..B-type natriuretic peptide (BNP) can effectively identify congestive heart failure in the emergency room setting but, despite increasing use, its diagnostic utility has not been validated in the intensive care unit (ICU)...
  4. pmc Identification of early acute lung injury at initial evaluation in an acute care setting prior to the onset of respiratory failure
    Joseph E Levitt
    Stanford University, 300 Pasteur Drive, Stanford, CA 94305, USA
    Chest 135:936-43. 2009
    ..To establish a definition of early ALI (EALI), we carried out a prospective cohort study to identify clinical predictors of progression to ALI...
  5. pmc The utility of clinical predictors of acute lung injury: towards prevention and earlier recognition
    Joseph E Levitt
    Division of Pulmonary Critical Care, Stanford University, 300 Pasteur Drive, MC 5236 Stanford, CA 94305, USA
    Expert Rev Respir Med 4:785-97. 2010
    ....
  6. ncbi request reprint Treatment of acute lung injury: historical perspective and potential future therapies
    Joseph E Levitt
    Division of Pulmonary and Critical Care, Stanford University, Stanford, California 94305, USA
    Semin Respir Crit Care Med 27:426-37. 2006
    ..This article focuses on clinical treatments for ALI that have been tested in phase II and III clinical trials as well as a discussion of potential future therapies...